{"id":"https://openalex.org/W7163672929","doi":"https://doi.org/10.3389/fmicb.2026.1865548","title":"Bacteriophage therapy against multidrug resistant bacterial infections demonstrates clinical advances and engineering innovations between 2020\u20132026","display_name":"Bacteriophage therapy against multidrug resistant bacterial infections demonstrates clinical advances and engineering innovations between 2020\u20132026","publication_year":2026,"publication_date":"2026-06-05","ids":{"openalex":"https://openalex.org/W7163672929","doi":"https://doi.org/10.3389/fmicb.2026.1865548","pmid":"https://pubmed.ncbi.nlm.nih.gov/42326420","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13279744"},"language":"en","primary_location":{"id":"doi:10.3389/fmicb.2026.1865548","doi":"https://doi.org/10.3389/fmicb.2026.1865548","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.1865548","pdf_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1865548/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1865548/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055499374","display_name":"Ahmed J. Alzahrani","orcid":"https://orcid.org/0009-0006-7754-0306","observed_orcids":["https://orcid.org/0009-0006-7754-0306"]},"institutions":[{"id":"https://openalex.org/I240666556","display_name":"Imam Mohammad ibn Saud Islamic University","ror":"https://ror.org/05gxjyb39","country_code":"SA","type":"education","lineage":["https://openalex.org/I240666556"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Ahmed J. Alzahrani","raw_affiliation_strings":["College of Medicine, Al-Imam Mohammad Ibn Saud Islamic University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medicine, Al-Imam Mohammad Ibn Saud Islamic University","institution_ids":["https://openalex.org/I240666556"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5055499374"],"corresponding_institution_ids":["https://openalex.org/I240666556"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":8.7629,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.9793749,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"17","issue":null,"first_page":"1865548","last_page":"1865548"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11048","display_name":"Bacteriophages and microbial interactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11048","display_name":"Bacteriophages and microbial interactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phage-therapy","display_name":"phage therapy","score":0.9980000257492065},{"id":"https://openalex.org/keywords/multidrug-resistant-bacteria","display_name":"multidrug-resistant bacteria","score":0.8519999980926514},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.9639999866485596},{"id":"https://openalex.org/keywords/phage-engineering","display_name":"phage engineering","score":0.8190000057220459},{"id":"https://openalex.org/keywords/compassionate-use-program","display_name":"compassionate use program","score":0.6299999952316284},{"id":"https://openalex.org/keywords/phage-antibiotic-combination-therapy","display_name":"phage-antibiotic combination therapy","score":0.8379999995231628},{"id":"https://openalex.org/keywords/personalized-phage-therapy","display_name":"personalized phage therapy","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C2779256223","wikidata":"https://www.wikidata.org/wiki/Q611870","display_name":"Phage therapy","level":5,"score":0.8493000268936157},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.5806000232696533},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.49239999055862427},{"id":"https://openalex.org/C2776441376","wikidata":"https://www.wikidata.org/wiki/Q165028","display_name":"Bacteriophage","level":4,"score":0.4887999892234802},{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.47760000824928284},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4603999853134155},{"id":"https://openalex.org/C2992053201","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Clinical efficacy","level":2,"score":0.42809998989105225},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.41359999775886536},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3734000027179718},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.36959999799728394},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.359499990940094},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3537999987602234},{"id":"https://openalex.org/C191908910","wikidata":"https://www.wikidata.org/wiki/Q862838","display_name":"Synthetic biology","level":2,"score":0.3319999873638153},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.31839999556541443},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3181000053882599},{"id":"https://openalex.org/C2992965680","wikidata":"https://www.wikidata.org/wiki/Q598976","display_name":"Clinical microbiology","level":2,"score":0.30329999327659607},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.296999990940094},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.2721000015735626},{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.2581999897956848}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fmicb.2026.1865548","doi":"https://doi.org/10.3389/fmicb.2026.1865548","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.1865548","pdf_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1865548/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},{"id":"pmid:42326420","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42326420","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in microbiology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13279744","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13279744/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Microbiol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:177807ac79b843f9bbc13e8988b5f79f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/177807ac79b843f9bbc13e8988b5f79f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Microbiology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fmicb.2026.1865548","doi":"https://doi.org/10.3389/fmicb.2026.1865548","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.1865548","pdf_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1865548/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7163672929.pdf","grobid_xml":"https://content.openalex.org/works/W7163672929.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W2944255770","https://openalex.org/W3081896631","https://openalex.org/W3184707527","https://openalex.org/W3195166090","https://openalex.org/W3199604146","https://openalex.org/W4289545349","https://openalex.org/W4402298723","https://openalex.org/W4402640385","https://openalex.org/W4403494194","https://openalex.org/W4405431416","https://openalex.org/W4406409627","https://openalex.org/W4413141504","https://openalex.org/W4414412662","https://openalex.org/W7082659994","https://openalex.org/W7125970299","https://openalex.org/W7127174109","https://openalex.org/W7127340515","https://openalex.org/W7128676876"],"related_works":["https://openalex.org/W7203828922","https://openalex.org/W7133598442","https://openalex.org/W4411191408","https://openalex.org/W7214112108","https://openalex.org/W4402640385","https://openalex.org/W7082659994","https://openalex.org/W7167092049","https://openalex.org/W4408087173","https://openalex.org/W7164565858","https://openalex.org/W4412885835"],"abstract_inverted_index":{"Purpose:":[0],"The":[1,168],"global":[2],"crisis":[3],"of":[4,170],"antimicrobial":[5],"resistance":[6,157],"has":[7,161],"reached":[8],"critical":[9],"levels,":[10],"with":[11,109],"multi-drug":[12],"resistant":[13],"(MDR)":[14],"bacterial":[15,77,193],"pathogens":[16],"threatening":[17],"to":[18,31],"render":[19],"conventional":[20],"antibiotics":[21],"ineffective.":[22],"This":[23],"mini":[24],"review":[25],"synthesizes":[26],"recent":[27],"evidence":[28,179],"from":[29],"2020":[30,81],"2026":[32],"on":[33,72],"bacteriophage":[34],"therapy":[35,74,182],"against":[36,191],"MDR":[37,76,192],"bacteria,":[38],"examining":[39],"clinical":[40,89,166,178],"applications,":[41],"engineering":[42,97],"advances,":[43],"mechanistic":[44],"insights,":[45],"and":[46,59,68,82,105,115,139,156,176],"emerging":[47],"technologies.":[48],"Methods:":[49],"A":[50],"comprehensive":[51],"literature":[52],"search":[53],"was":[54],"conducted":[55],"across":[56],"Embase,":[57],"Scopus,":[58],"Cochrane":[60],"Library":[61],"databases,":[62],"supplemented":[63],"by":[64],"PubMed,":[65],"Google":[66],"Scholar,":[67],"ArXiv":[69],"searches,":[70],"focusing":[71],"phage":[73,93,141,181],"for":[75],"infections":[78],"published":[79],"between":[80],"2026.":[83],"Results:":[84],"Recent":[85],"developments":[86],"include":[87],"expanded":[88],"experience":[90],"through":[91],"specialized":[92],"centers,":[94],"sophisticated":[95],"genetic":[96],"techniques":[98],"including":[99],"CRISPR-based":[100],"systems,":[101],"successful":[102],"compassionate-use":[103],"programs,":[104],"innovative":[106],"combination":[107],"therapies":[108],"antibiotics.":[110],"Clinical":[111],"reports":[112],"demonstrate":[113],"safety":[114],"preliminary":[116],"efficacy":[117],"signals":[118],"in":[119,151,188],"selected":[120],"refractory":[121],"infections,":[122],"though":[123],"randomized":[124],"controlled":[125],"data":[126],"remain":[127,150],"limited.":[128],"Engineering":[129],"advances":[130],"have":[131],"produced":[132],"phage-delivered":[133],"CRISPR":[134],"antimicrobials,":[135],"hybrid":[136],"delivery":[137],"platforms,":[138],"synthetic":[140,171],"particles":[142],"that":[143],"expand":[144],"therapeutic":[145],"capabilities.":[146],"Conclusion:":[147],"While":[148],"challenges":[149],"regulatory":[152],"standardization,":[153],"scalable":[154],"manufacturing,":[155],"management,":[158],"the":[159,189],"field":[160],"demonstrated":[162],"significant":[163],"progress":[164],"toward":[165],"translation.":[167],"convergence":[169],"biology,":[172],"personalized":[173],"medicine":[174],"approaches,":[175],"growing":[177],"positions":[180],"as":[183],"a":[184],"viable":[185],"complementary":[186],"strategy":[187],"fight":[190],"infections.":[194]},"counts_by_year":[{"year":2026,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-06-06T00:00:00"}